Your browser doesn't support javascript.
loading
Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations.
Bayraktar, Soley; Zhou, Jade Z; Bassett, Roland; Gutierrez Barrera, Angelica M; Layman, Rachel M; Valero, Vicente; Arun, Banu.
Affiliation
  • Bayraktar S; Division of Medical Oncology and Hematology, Department of Medicine, Biruni University School of Medicine, Istanbul, Turkey.
  • Zhou JZ; Departments of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Bassett R; Departments of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Gutierrez Barrera AM; Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Layman RM; Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Valero V; Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Arun B; Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Breast J ; 26(8): 1572-1582, 2020 08.
Article in En | MEDLINE | ID: mdl-32497289
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Germ-Line Mutation Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Breast J Journal subject: NEOPLASIAS Year: 2020 Type: Article Affiliation country: Turkey
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Germ-Line Mutation Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Breast J Journal subject: NEOPLASIAS Year: 2020 Type: Article Affiliation country: Turkey